DaVita HealthCare Partners Inc (DVA)
Return on equity (ROE)
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | 691,535 | 608,973 | 467,707 | 513,825 | 560,400 | 679,770 | 834,158 | 903,169 | 978,450 | 964,750 | 863,670 | 771,452 | 773,642 | 844,740 | 829,336 | 901,285 | 810,981 | 416,338 | 136,272 | 129,997 |
| Total stockholders’ equity | US$ in thousands | 1,056,100 | 1,199,200 | 1,017,440 | 825,470 | 712,326 | 532,672 | 604,784 | 843,771 | 755,508 | 1,149,440 | 1,277,780 | 1,248,110 | 1,383,570 | 1,574,760 | 2,153,920 | 1,947,850 | 2,133,410 | 2,318,580 | 4,049,300 | 3,875,350 |
| ROE | 65.48% | 50.78% | 45.97% | 62.25% | 78.67% | 127.62% | 137.93% | 107.04% | 129.51% | 83.93% | 67.59% | 61.81% | 55.92% | 53.64% | 38.50% | 46.27% | 38.01% | 17.96% | 3.37% | 3.35% |
December 31, 2023 calculation
ROE = Net income (ttm) ÷ Total stockholders’ equity
= $691,535K ÷ $1,056,100K
= 65.48%
The return on equity (ROE) of DaVita Inc has shown fluctuating trends over the past eight quarters. In Q4 2023, the ROE stood at 65.48%, which is lower compared to the previous quarter's ROE of 50.78%. Despite this decrease, the company's ROE remains relatively strong, indicating that DaVita Inc is effectively utilizing shareholder equity to generate profits.
Looking back over the past two years, DaVita Inc's ROE has experienced significant variations. In Q3 2022 and Q2 2022, the company had exceptionally high ROE figures of 127.62% and 137.93% respectively, indicating strong profitability and efficient management of shareholder investments during that period. However, recent quarters have shown a downward trend in ROE, with Q2 2023 and Q1 2023 recording ROE figures of 45.97% and 62.25% respectively.
Overall, while DaVita Inc's ROE has experienced fluctuations, the company has demonstrated an ability to generate favorable returns for its shareholders. It will be important to monitor future financial performance to assess whether the recent downward trend in ROE is temporary or indicative of broader underlying challenges.
Peer comparison
Dec 31, 2023